MedPath

Protein Requirements for Active Adolescent Males (IAAO-AM)

Not Applicable
Completed
Conditions
Healthy
Interventions
Dietary Supplement: Amino Acid Intake
Registration Number
NCT02859181
Lead Sponsor
University of Toronto
Brief Summary

Protein requirements in active individuals have been suggested to be greater than the current recommended dietary allowance (RDA).

Nutritional requirements for dietary amino acids in adolescents have traditionally been determined utilizing the nitrogen balance technique, which is prone to underestimating protein requirements. As a result, there is a need to re-evaluate recommendations in order to characterize how dietary amino acid needs may be modulated by physical activity.

Recent studies using the minimally invasive indicator amino acid oxidation (IAAO) technique have suggested that protein requirements in young men are at least 50% higher than the RDA based on nitrogen balance data.

The purpose of this study is to measure the protein requirement in adolescent, males using the IAAO technique in the presence of a variable intensity exercise stimulus.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
7
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Active, Adolescent malesAmino Acid IntakeSubjects will receive different levels of amino acid intakes, varying from 0.2-2.67 g/kg/d
Primary Outcome Measures
NameTimeMethod
13CO2 ([13]Carbon Dioxide) Excretion (µmol/kg/h)4 hours per study day

Each trial day will assess a different protein intake with 13CO2 excretion defining the level of protein adequacy. Each trial day will be separated by \~1wk washout with all trial being completed in approximately 3 months.

Secondary Outcome Measures
NameTimeMethod
[13C]Phenylalanine Oxidation (µmol/kg/h)4 hours per study day

Each trial day will assess a different protein intake with 13CO2 excretion defining the level phenylalanine oxidation being used as a secondary marker of protein adequacy. Each trial day will be separated by \~1wk washout with all trial being completed in approximately 3 months.

Trial Locations

Locations (1)

Goldring Centre for High Performance Sport

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath